Search This Blog

Friday, October 5, 2018

Ionis and Akcea shares halted pending news


Nasdaq has suspended trading in Ionis Pharmaceuticals (IONS +2.7%) and Akcea Therapeutics (AKCA +5.2%) pending the release of news, most certainly related to the FDA decision on inotersen for hATTR.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)